Login to Your Account


$2.6 billion raised so far

Barely five months into 2018, investors have placed more seed and series A money into biotherapeutics companies than all of last year. At this pace, the $2.6 billion raised could translate to more than $6 billion by year's end – more than double the amounts logged for the two highest years on record, 2015 and 2016.

more »


Our Habitat for All Things Science
GWAS in Chinese population implicates immune system in Alzheimer's disease

A study has identified common genetic variants in the Chinese population contributing to the risk of developing Alzheimer's disease (AD) that possibly exert functional effects through the immune system, which could have important implications for AD management.

The search continues for promising biomarkers and effective disease-modifying therapies for AD. The current drug development approaches mainly target the disease's hallmark pathology of amyloid-beta (Abeta) protein accumulation in the brain leading to Abeta plaque deposition.

READ MORE »

Opinion


Partners in Focus